CClinicalTrials.gg
CompletedNCT04125992DRAvsFRAUpdated Jun 6, 2023

Distal vs. Forearm Radial Artery Access

An interventional study of distal radial artery access in coronary angiography and angioplasty and Forearm radial artery access in coronary angiography and angioplasty in Coronary Artery Disease, Angina, Unstable and Angina, Stable, sponsored by An-Najah National University. Completed at 1 site in Palestinian Territory, occupied. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-06.

Sponsored by An-Najah National University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
212
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The Distal Radial Access (DRA) to the coronaries has emerged recently. It's done via the distal radial artery in the radial fossa, which is known as the snuff-box. The rationale of conducting this research is to assess this new access advantages and disadvantages, in comparison with the standard conventional forearm radial access and examine if it's worthy to be a future alternative method for coronary angiography. It aims to randomly compare between the new distal radial access via the snuffbox and the conventional forearm radial access for percutaneous coronary angiography and angioplasty procedures. The objectives of comparing both procedures are to analyze the frequency of complications in terms of occlusion, arterial spasm, hematoma, and to weigh accesses effectiveness in terms of time and attempts to puncture, crossover rate, procedure duration, hemostasis time, and convenience of the patients and operators.

Candidates for coronary angiography are being randomized into the interventional group to undergo the angiography through the distal radial artery as the access site, or the control group accessing through the radial artery in the forearm. Procedural and post procedural outcomes and complications are being reported while patients are in hospital. All patients undergo doppler ultrasonography within 24 hours after the procedure.

02

Conditions studied

  • Coronary Artery Disease
  • Angina, Unstable
  • Angina, Stable
  • Non STEMI
  • Non ST Segment Elevation Myocardial Infarction
  • Acute Coronary Syndrome
  • Atheroscleroses, Coronary
  • Atherosclerotic Heart Disease With Ischemic Chest Pain
  • Chest Pain
  • Myocardial Infarction
  • Myocardial Ischemia
  • ST-segment Elevation Myocardial Infarction (STEMI)

Keywords

  • cardiac catheterization
  • coronary angiography
  • coronary angioplasty
  • snuff-box
  • snuffbox
  • snuff box
  • radial fossa
  • distal radial artery
  • radial artery
  • safeguard
  • distal radial access
  • distal radial angiography
  • radial access
  • angiography
  • distal radial
  • radial
  • coronary arteries
  • randomized controlled trial
  • left distal radial artery
  • Percutaneous Coronary Intervention
  • radial artery occlusion
  • forearm radial access
  • forearm radial artery
  • coronary catheterization
  • catheterization
  • left distal radial
  • angioplasty
  • coronary artery disease
  • radial vs distal
03

In context

Coronary Artery Disease

5,598 studies on the registry are indexed under Coronary Artery Disease; 957 are open to participants now.

This study's enrollment of 212 is above the median of 124 across 3,436 interventional studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

An-Najah National University is the lead sponsor of 5 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients who agree to participate in the study and sign the consent form.
  • Patients with an indication for coronary catheterization
  • Clinically stable patients
  • Patients with palpable pulses on both access sites of the radial artery.

Exclusion criteria

Exclusion Criteria:

  • Patients with STEMI
  • Patients with radial AV shunt for hemodialysis
  • Patients with previous CABG using radial artery
  • Patients with previous CABG using LIMA, RIMA or both.
  • Patients with Renaud phenomenon or lymphedema
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
212 participants (actual)

Study arms

  • Experimental
    Distal Radial

    Patients who undergo coronary catheterization by accessing the distal radial artery in the snuff-box of the hand.

    Procedure: distal radial artery access in coronary angiography and angioplasty

  • Active comparator
    Forearm Radial

    Patients who undergo conventional coronary catheterization by accessing the forearm radial artery.

    Procedure: Forearm radial artery access in coronary angiography and angioplasty

Interventions

  • Proceduredistal radial artery access in coronary angiography and angioplasty

    The patient grasps his thumb towards the palm to bring the radial artery up to the surface. The left hand is set on the right side of the groin toward the operator, who stands on the right side, with the dorsal surface of hand upwards. Afterward, the access site is disinfected, lidocaine HCL is SC injected for local anesthesia. Subsequently, the distal radial artery is palpated to find the point of the strongest pulse. Later, at a 45-degree angle, the artery is punctured with a 21-gauge needle and a 0.018 soft, flexible, metallic wire is then inserted in the needle. Through the sheath, 200 micrograms of Nitroglycerin is given. A 5000 unit of unfractionated heparin is administered through the IV line. A weight-adjusted dose of heparin is further added if PCI is needed. Then, a 0.035 wire is introduced in the sheath with other required instruments such as the intracoronary device and the catheters. After pulling out the sheath, a compression device, Safe Guard, is used for hemostasis.

  • ProcedureForearm radial artery access in coronary angiography and angioplasty

    The right hand is set in the anatomical position, with the anterior surface of arm face upwards. Afterward, the access site is disinfected, lidocaine HCL is SC injected for local anesthesia. Subsequently, the forearm radial artery is palpated to find the point of the strongest pulse. Later, at a 45-degree angle, the artery is punctured with a 21-gauge needle and a 0.018 soft, flexible, metallic wire is then inserted in the needle. Through the sheath, 200 micrograms of Nitroglycerin is given. A 5000 unit of unfractionated heparin is administered through the IV line. A weight-adjusted dose of heparin is further added if PCI is needed. Then, a 0.035 wire is introduced in the sheath with other required instruments such as the intracoronary device and the catheters. After pulling out the sheath, a compression device, TR band, is used for hemostasis.

06

What researchers measure

Primary outcomes

  1. Radial artery occlusion

    Doppler Ultrasonography of the radial artery for occlusions along its course, in both groups.

    Time frame: Within 24 hours after the procedure.

Secondary outcomes

  1. Puncture Time

    Which is time from first attempt to puncture to the successful one in seconds

    Time frame: During the procedure

  2. Puncture Attempts

    Which is the number of puncture attempts from first one until the successful one (maximum 6)

    Time frame: During the procedure

  3. Procedure Duration

    In minutes from the insertion of the sheath to its exertion.

    Time frame: During the procedure

  4. Radiation Duration

    Which is measured by the radiological device in minutes.

    Time frame: During the procedure

  5. Radiology Dose

    Which is measured by the radiological device in mGy.

    Time frame: During the procedure

  6. Compression "hemostasis" time

    The time from the placement of the compression band until its removal (when there's no blood oozing after deflation), measured by minutes.

    Time frame: Up to 240 minutes after band placement

  7. Arterial spasm

    Which is assessed by the operator if present or absent in terms of the difficulty in inserting the wire at the time of the procedures. of the procedure.

    Time frame: During the procedure

  8. Hematoma and bleeding complications

    It is defined by EASY hematoma scale.

    Time frame: Within 24 hours after the procedure

  9. Ischemic changes to the hand

    It is noted by clinical features of pallor, absence of pulse, pain, cold, paresthesia or paralysis.

    Time frame: Within 24 hours after the procedure

  10. Crossover (failure to puncture)

    It is transforming from the selected access to another after 6 failed attempts to puncture the first selected access

    Time frame: During the procedure

  11. Procedural pain

    Assessed by numerical rating scale (NRS) for pain, which is an 10 point subjective scale (0-10) where 0 refers for no pain, 1-3 for mild pain, 4-6 for moderate pain and 7-10 for severe pain.

    Time frame: During the procedure

  12. Post-procedural pain

    Assessed by numerical rating scale (NRS) for pain, which is an 11 point subjective scale (0-10) where 0 refers for no pain, 1-3 for mild pain, 4-6 for moderate pain and 7-10 for severe pain.

    Time frame: Within 24 hours after the procedure

  13. Rare complications

    Pseudo-aneurysm, AV fistula formation, radial artery dissection, which are assessed by Doppler US. In addition to radial artery eversion or perforation.

    Time frame: Within 24 hours after the procedure

  14. Radial Artery Occlusion on follow up

    Follow up Doppler Ultrasonography for patients with occluded radial artery within 24 hours.

    Time frame: After 2 weeks of the procedure.

07

Study locations

1 site
  • An-Najah National University Hospital
    Nablus, Palestinian Territory, occupied
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04125992
Lead sponsor
An-Najah National University
Responsible party
Yunis Daralammouri (Assistant Professor, An-Najah National University) — Principal investigator
First posted
Oct 14, 2019
Start date
Dec 1, 2019
Primary completion
Dec 21, 2020
Completion
Dec 21, 2020
Last update
Jun 6, 2023

Study contacts

Yunis Daralammouri, asst. prof.
principal investigator · An-Najah National University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion